 |
|
| Blog results | Results 1 - 10 of about 231 for taxotere 35 mg. (0.26 seconds) |
| Sorted by relevance Sort by date |
| 24 Nov 2009 by de la Fouchardiere, C., Largillier, R.,... Patients and methods: MBC patients were enrolled to receive six cycles of PLD 35 mg/m2 (day 1) and docetaxel 40 mg/m2 (days 1 and 15), every 28 days (group A). Because of unacceptable toxic effects, doses were modified to PLD 30 mg/m2 ... Annals of Oncology - recent issues - http://annonc.oxfordjournals.org/ [ More results from Annals of Oncology - recent issues ] |
| 28 May 2009 Based on independent radiologist review, the ORR for the 150 mg/m2 and 100 mg/m2 dose arms and docetaxel were 49 percent, 45 percent, and 35 percent respectively. Investigator assessments of the ORR were higher for the weekly ABRAXANE ... Drugs.com - Clinical Trials - http://www.drugs.com/clinical_trials.html [ More results from Drugs.com - Clinical Trials ] |
| 9 Sep 2009 by Dr. NICK the women were randomized to receive either docetaxel (75 mg/m ) monotherapy or liposomal doxorubicin (30 mg/m ) followed by docetaxel (60 mg/m ) every 21 days. therapy was continued until disease progression or prohibitive toxicity. ... CANCER AND IMPORTANT MEDICAL NEWS - http://cancerology.blogspot.com/ [ More results from CANCER AND IMPORTANT MEDICAL NEWS ] |
| 25 Oct 2007 The approval was based on data from a prospective phase 1 pharmacokinetic study of 35 patients with various degrees of renal impairment, including none (creatinine clearance [CrCl] ≥ 60 mL/minute/1.73 m 2; n = 12), ... In the study, patients were treated every 3 weeks for 3 cycles with docetaxel 75 mg/m 2 plus cisplatin 100 mg/m 2 and 5-fluorouracil 1000 mg/m 2 a day for 4 days, or intravenous cisplatin 100 mg/m 2 and 5-fluorouracil 1000 mg/m 2 a day for 5 days. ... Medscape Pharmacists Headlines - http://www.medscape.com/pharmacists?src=rss |
| 28 Aug 2009 by jacquie strax For some men with hormone-resistant prostate cancer (HRPC) who would be willing to accept Taxotere alone as a chemotherapy, and who are interested in a chance to receive in addition a potentially potent therapy, this clinical trial might be ... At the primary analysis, median time to progression was 3.6 mo, 4.0 mo, and 3.8 mo in the placebo, ZD4054 10 mg, and ZD4054 15 mg groups, respectively, with no statistically significant difference between ZD4054 groups and placebo. ... PSA Rising Prostate Cancer Blog - http://psa-rising.com/blog/ - References |
| 19 Mar 2009 by Sara López-Tarruella and Miguel Martín The Taxotere as Adjuvant Chemotherapy trial [27] is the largest first-generation taxane-based adjuvant trial conducted to date. It compared four cycles of FE60C (fluorouracil 600 mg/m2, epirubicin 60 mg/m2, and cyclophosphamide 600 mg/m2 every 3 ... All patients received AC for four cycles followed by taxane treatment, either docetaxel or paclitaxel, for 12 weeks in a weekly schedule (80 mg/m2 paclitaxel and 35 mg/m2 docetaxel) or every 3 weeks for four cycles (175 mg/m2 ... Breast Cancer Research - Latest articles - http://breast-cancer-research.com/ [ More results from Breast Cancer Research - Latest articles ] |
| 13 Aug 2007 by Dr. West this latter trial enrolled 37 patients with previously treated advanced nsclc and gave taxotere 70-75 mg/m2 with tarceva at 150-200 mg/day (day 2 to 16 every 21 days). they saw a response rate of 35% (11 of 34 evaluable), which is very ... Onctalk - http://onctalk.com/ [ More results from Onctalk ] |
| 31 Jan 2006 by Karen i went through my notes last night on how i reacted the last time i was on taxotere. in 2002, i was dosed at 35 mg/m squared and received it weekly for 14 straight weeks. i never developed neuropathy per se; instead, around week 11 i ... Karen - http://kamigirl25.livejournal.com/ |
| 26 Jun 2008 by E. Michael D. ("Mike") Scott All patients were treated with androgen deprivation therapy (6.3 mg buserelin acetate every 8 weeks for three doses and an antiandrogen for 4 weeks) with docetaxel (35 mg/m2 weekly for 6 of 8 weeks for three doses). ... THE "NEW" PROSTATE CANCER INFOLINK - http://prostatecancerinfolink.net/ [ More results from THE "NEW" PROSTATE CANCER INFOLINK ] |
| 27 May 2008 by Rx Times surgery to receive either tac (docetaxel 75 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2) or fac (5-fluorouracil 500 mg/m2, doxorubicin 50 mg/m2, cyclophosphamide 500 mg/m2) every 3 weeks for 6 cycles. ... Rx Times - Pharmacy Magazine - http://www.rxtimes.com/ |
Stay up to date on these results:
| Google Home - About Google Blog Search Beta - Information for Blog Authors |
